Comparison of effects of Empagliflozin and Linagliptin on renal function and glycaemic control: a double-blind, randomized clinical trial

BACKGROUND: This study aimed to compare the effects of Linagliptin and Empagliflozin on renal function and glycaemic control in patients with type 2 diabetes mellitus (DM). METHOD: We conducted a randomized, double-blind, parallel trial on patients aged 30 to 80 years with type 2 DM and HbA1c ≤ 9%,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad zadeh Gharabaghi, Mohammad Amin, Rezvanfar, Mohammad Reza, Saeedi, Nasser, Aghajani, Faezeh, Alirezaei, Mohammad, Yarahmadi, Pourya, Nakhostin-Ansari, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131518/
https://www.ncbi.nlm.nih.gov/pubmed/35610696
http://dx.doi.org/10.1186/s40842-022-00142-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131518/
https://www.ncbi.nlm.nih.gov/pubmed/35610696
http://dx.doi.org/10.1186/s40842-022-00142-1

Ejemplares similares